News & Updates
Filter by Specialty:
Low use of CVD prevention strategies in people with HIV
There is an underutilization of cardiovascular disease (CVD) prevention strategies in people living with HIV (PLHIV) who are at risk of CVD, according to a study presented at HIV Glasgow 2022.
Low use of CVD prevention strategies in people with HIV
18 Nov 2022Low antithrombin levels tied to ECMO ventilation in COVID-19 patients
Low levels of antithrombin upon admission to the intensive care unit (ICU) appears to increase the need for extracorporeal membrane oxygenation (ECMO) among patients with COVID-19, reports a recent study.
Low antithrombin levels tied to ECMO ventilation in COVID-19 patients
18 Nov 2022Moderate dairy intake protects against COVID-19
Modest consumption of total dairy may lower the likelihood of contracting COVID-19 by 37 percent, while a higher intake of low-fat dairy products provides a protective benefit, reports a study.
Moderate dairy intake protects against COVID-19
17 Nov 2022Joint replacement ERAS program reforms surgical care during pandemic
Effective multidisciplinary collaborations with Enhanced Recovery After Surgery (ERAS) pathways result in improved services and deliver continued care despite restrictions caused by the COVID-19 pandemic and same-day admission limitations, according to a single-centre study presented at the Anesthesiology Annual Meeting 2022. To date, feedback from patients has been encouraging.
Joint replacement ERAS program reforms surgical care during pandemic
15 Nov 2022COVID-19 infection affects faecal microbiota and this condition may persist long after recovery from the disease.
COVID-19 infection is associated with faecal microbiota dysbiosis*, especially those that cause more severe disease, says a prominent researcher. However, there is ambiguity as to whether it is a meaningful association or an epiphenomenon**.
COVID-19 infection affects faecal microbiota and this condition may persist long after recovery from the disease.
15 Nov 2022Dolutegravir: A better choice for HIV viral suppression in pregnancy?
Among pregnant individuals on antiretroviral therapy (ART) for HIV-1 infection, those on dolutegravir had the greatest viral suppression rates at delivery, a recent US-based observational study showed. However, birth outcomes generally did not differ between dolutegravir recipients and those on various other ART regimens.